Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

7 May 2014 12:33

RNS Number : 4757G
Mandarin Oriental International Ltd
07 May 2014
 

To: Business Editor For immediate release

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

7th May 2014 ‒ Mandarin Oriental International Limited has today issued its Interim Management Statement covering the period from 1st January to 6th May 2014.

 

The trading performance across the Group during the period was broadly stable. In Asia, the results of the Hong Kong and Singapore hotels remained steady, while Bangkok continued to be affected by challenging conditions. Europe benefited from further stabilization of the Paris hotel and improvement in Geneva, which more than offset softer demand in London. In The Americas, while the majority of hotels increased their average rates, the overall performance was impacted by lower demand in Washington when compared to the same period last year, which included the 2013 Presidential Inauguration.

 

In March, the Group entered into an agreement with a local development partner to expand its wholly-owned hotel in Munich. A mixed-use complex is to be constructed on an adjacent site that will include a hotel element in which the Group will have a freehold interest. The Group's total projected investment in the complex, which is due to open in 2021, is estimated at €124 million (US$170 million) in today's terms, and will include a refurbishment of the existing hotel's rooms.

 

During the period, a new management contract was announced for a 121-room luxury resort located on Bali's southern peninsula, scheduled to open in 2017. The Group has ceased management of two unbranded hotels; the Grand Lapa hotel in Macau in January and the Elbow Beach hotel in Bermuda in March.

 

Two new hotels are scheduled to open within the next six months, in Taipei, Taiwan and in Bodrum, Turkey.

 

The Group's financial position remains healthy, with net debt remaining in line with that reported at 31st December 2013.

 

On 8th April 2014 shareholders approved the transfer of the Company's share listing on the Main Market of the London Stock Exchange to the standard segment from the premium segment. The transfer is expected to become effective on 27th May 2014.

 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the most luxurious hotels, resorts and residences. Having grown from a well-respected Asian hotel company into a global brand, the Group now operates, or has under development, 44 hotels representing close to 11,000 rooms in 25 countries, with 20 hotels in Asia, ten in The Americas and 14 in Europe, Middle East and North Africa. In addition, the Group operates or has under development, 13 Residences at Mandarin Oriental connected to its properties. Mandarin Oriental International Limited is incorporated in Bermuda and has its primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

Hamish Ross (852) 2895 9288

Sally de Souza (852) 2895 9167

 

GolinHarris

Kennes Young (852) 2501 7987

 

This and other Group announcements can be accessed through the internet at 'www.mandarinoriental.com'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFDLFBZEFXBBL
Date   Source Headline
19th Jan 20261:45 pmRNSCompletion of Acquisition by Jardine Strategic
16th Jan 20267:00 amRNSCourt Sanction of Scheme of Arrangement
9th Jan 20269:19 amRNSOCB Dividend
31st Dec 20257:22 amRNSUpdate on OCB Sale and Acquisition Timeline
31st Dec 20257:22 amRNSUpdate on OCB Sale and Acquisition Timeline
8th Dec 20253:47 pmRNSResults of Court Meeting & Special General Meeting
21st Nov 20259:58 amRNSInterim Management Statement
14th Nov 202511:37 amRNSReplacement: Publication of Shareholder Circular
14th Nov 20259:38 amRNSAnnouncement (Publication of Shareholder Circular)
17th Oct 202510:24 amRNSRecommended Cash Acquisition of Mandarin Oriental
17th Oct 202510:21 amRNSSale of 301,555 sq.ft. of One Causeway Bay
2nd Oct 202510:20 amRNSDividend Declaration
30th Sep 20257:00 amRNSRESPONSE TO MEDIA SPECULATION
25th Sep 202510:23 amRNSBlock listing Interim Review
28th Jul 202512:33 pmRNSHalf-year Results
11th Jul 202510:28 amRNSNotification to Untraced Shareholders
15th May 202511:44 amRNSINTERIM MANAGEMENT STATEMENT
2nd May 20251:02 pmRNSResult of AGM
30th Apr 202510:24 amRNSDividend Declaration
7th Apr 202510:39 amRNSAnnual Financial Report
25th Mar 20259:20 amRNSBlock listing Interim Review
5th Mar 20251:42 pmRNS2024 PRELIMINARY RESULTS
14th Nov 20249:43 amRNSINTERIM MANAGEMENT STATEMENT
4th Nov 20249:22 amRNSDirectorate Change
2nd Oct 202410:26 amRNSDividend Declaration
25th Sep 202410:19 amRNSBlock listing Interim Review
31st Jul 202410:17 amRNSCompany Board Change
24th Jul 20243:06 pmRNSHalf-year Report
16th Jul 202410:49 amRNSCompany Board Changes
12th Jun 202411:59 amRNSDisposal
23rd May 202410:44 amRNSINTERIM MANAGEMENT STATEMENT
8th May 202412:38 pmRNSResult of AGM
2nd May 202410:23 amRNSDividend Declaration
9th Apr 202410:28 amRNSAnnual Financial Report
25th Mar 20249:26 amRNSBLOCK LISTING INTERIM REVIEW
7th Mar 202410:04 amRNS2023 Preliminary Results
1st Mar 20249:25 amRNSCHANGE OF SINGAPORE BRANCH REGISTRAR
22nd Dec 20231:18 pmRNSMO Signs Option to sell MO, Paris
24th Nov 20239:22 amRNSDirectorate Change
9th Nov 20239:54 amRNSINTERIM MANAGEMENT STATEMENT
27th Sep 202310:28 amRNSDividend Declaration
25th Sep 202310:33 amRNSBlock listing Interim Review
1st Sep 202310:27 amRNSDirector Declaration
28th Jul 202310:33 amRNSHalf-year Results
18th May 202310:23 amRNSInterim Management Statement
4th May 202312:31 pmRNSResult of AGM
2nd May 202310:17 amRNSDirectorate Change
3rd Apr 202310:26 amRNSAnnual Financial Report
31st Mar 202310:24 amRNSTotal Voting Rights
27th Mar 202310:30 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.